Creades stock: fair value
CRED-A.STThe fair value of Creades under our model is $11.45, the price is 25% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Modestly undervaluedIn our model the price counts as cheap below $8.18 and expensive above $19.08 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $2.70 (cash-flow model) and $20.20 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 7.2%. At 8.2% the fair value would be $11.22, at 6.2% it would be $11.80.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (14).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 2.2%. Discounted at 7.2% (floor: government bond yield 2.2% plus 5 percentage points, since beta 0.8 times the risk premium would give less); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $2.70 per share: free cash flow for the next ten years, each year discounted to today at 7.2%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 7.2%) |
|---|---|---|---|---|
| 2026 | $14.64M | extrapolated at 14.1% | 0.9330 | $13.66M |
| 2027 | $16.17M | extrapolated at 10.5% | 0.8705 | $14.08M |
| 2028 | $17.47M | extrapolated at 8.0% | 0.8122 | $14.19M |
| 2029 | $18.56M | extrapolated at 6.3% | 0.7578 | $14.06M |
| 2030 | $19.49M | extrapolated at 5.0% | 0.7070 | $13.78M |
| 2031 | $20.31M | extrapolated at 4.2% | 0.6597 | $13.39M |
| 2032 | $21.03M | extrapolated at 3.6% | 0.6155 | $12.94M |
| 2033 | $21.7M | extrapolated at 3.2% | 0.5742 | $12.46M |
| 2034 | $22.32M | extrapolated at 2.9% | 0.5358 | $11.96M |
| 2035 | $22.91M | extrapolated at 2.7% | 0.4999 | $11.45M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $131.97M |
| Terminal value: cash flow 2035 × (1 + 2.2%) / (7.2% − 2.2%) | $468.2M |
| Present value of terminal value (× 0.4999) | $234.04M |
| Equity value (sum plus present value of terminal value) | $366.02M |
| Shares (diluted) | 135.76M |
| Value per share (equity value divided by shares) | $2.70 |
| Earnings per share, last twelve months | $1.45 |
| × 14 (industry P/E) | $20.20 |
| Fair value (average of both parts) | $11.45 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Apr 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.